A-Z page index

A B C D E F G H I J K L M N
O P Q R S T U V W X Y Z

Translate DermNet NZ

from English to German English to Spanish English to French English to Italian English to Portuguese English to Russian BETA English to Arabic BETA English to Japanese BETA English to Korean BETA English to Chinese (S) BETA

Buy skin care products

Search for books

Azathioprine and mercaptopurine

Azathioprine is a thiopurine analogue drug that suppresses the immune system by altering white blood cell function. It is changed in the liver to a related drug, mercaptopurine and then into metabolites called thioguanine (tioguanine) nucleotides, which inhibit cell growth.

Azathioprine and mercaptopurine are used in a number of skin disorders such as:

• Severe atopic dermatitis (eczema)
• Bullous pemphigoid
• Pemphigus vulgaris
• Cutaneous polyarteritis nodosa
• Pyoderma gangrenosum
• Severe cutaneous lupus erythematosus
• Cutaneous vasculitis

In New Zealand azathioprine is available as 50mg tablets or as an injection, trade name Imuran®, Azamun® or Thioprine®. Mercaptopurine is available as 10mg or 50mg tablets, trade name Puri-nethol®. The dose is generally one or two tablets once or twice daily. Occasionally doses as high as 5mg per kg body weight per day prove necessary.

Side effects and risks

Side effects are generally mild but occasionally are severe enough to stop treatment with azathioprine or mercaptopurine.

• Loss of appetite, nausea, vomiting or diarrhoea (more common if the medications is taken on an empty stomach). Mouth ulceration may also occur.
• Liver upset (cholestatic hepatitis). Allergy to azathioprine usually affects the liver, most often several weeks after starting treatment.
• Pancreatitis
• Bone marrow suppression, particularly leucopaenia (reduced number of white blood cells); azathioprine should be stopped if the neutrophil count drops below 1.0x10^9/L, the lymphocyte count drops below 0.5x10^9/L or the platelet count below 50x10^9/L.
• Megabloblastic erythropoeisis or macrocytosis (production of large red blood cells).
• Rarely, severe prolonged drug hypersensitivity syndrome resulting in widespread rash, fever, enlarged lymph glands and organ failure (heart, lungs, kidneys, liver).
• Hair loss
• Skin cancer is more likely after several years´ treatment with azathioprine, especially on skin that has been exposed to the sun. Protect your skin from the sun at all times, using a broad spectrum sunscreen on exposed areas every day.

Azathioprine and mercaptopurine are FDA Pregnancy Category D. Where possible, these drugs should not be taken during pregnancy, except where the benefits outweigh the risks. Those taking these medications should not breast feed. In some circumstances it may also be advisable for males to ensure their partners do not become pregnant. Discuss your own situation with your physician.

Monitoring

Patients taking azathioprine or mercaptopurine should receive regular blood tests to monitor the safety of treatment, at first fortnightly then monthly long term.

• Complete blood count (CBC or FBC)
• Liver function tests.

Azathioprine and mercaptopurine are not metabolised properly by some people, who have a faulty enzyme called thiopurine methyltransferase. They may have one gene for the bad enzyme (found in 11% of the population) or two (0.3%). Those with both genes are at severe risk of dangerous marrow suppression i.e. reduction of white cells (leucopaenia) or of all blood cells (pancytopaenia). Some individuals have high levels of enzyme activity and may require a higher dose than normal for therapeutic effect.

Thiopurine methyltransferase levels can be measured to determine a patient's level of risk before starting treatment. 6-Thioguanine nucleotide levels are sometimes used to check whether the dose is correct.

Drug interactions

If you take azathioprine, you must advise any medical practitioner or pharmacist. It is particularly important if you take allopurinol for gout, as the dose of azathioprine will need to be reduced to one-quarter to one-third of normal to avoid severe toxicity.

The following drugs are best avoided, but if unavoidable it is important to monitor blood count very carefully:

• Neuromuscular blocking agents (such as rocuronium, mivacurium, vercuronium, atracurium, tubocurarine)
• Warfarin (the warfarin dose requirement may go up by 3-4 times during treatment with azathioprine)
• D-penicillamine
• Cotrimoxazole
• Captopril, enalapril, lisinopril and other angiotensin-converting enzyme (ACE) inhibitors
• Cimetidine
• Indomethacin
• Sulfasalazine and other benzoic acid derivatives
• Live vaccines